COMPUTATIONAL DESIGN OF NORBORNANE-BASED HIV-1 PROTEASE INHIBITORS

被引:4
|
作者
Zhang, Dawei [1 ]
Yu, Liu Ze [1 ]
Huang, Philip Lin [2 ]
Lee-Huang, Sylvia [3 ]
Zhang, John Z. H. [4 ,5 ]
机构
[1] Nanyang Technol Univ, Sch Phys & Math Sci, Div Chem & Biol Chem, Singapore 637371, Singapore
[2] Amer Biosci, Boston, MA 02114 USA
[3] NYU, Dept Biochem, Langone Med Ctr, New York, NY 10016 USA
[4] E China Normal Univ, Dept Phys, State Key Lab Precis Spect, Shanghai 200062, Peoples R China
[5] NYU, Dept Chem, New York, NY 10003 USA
关键词
HIV-1; protease; norbornane-based inhibitor; linear interaction energy; FREE-ENERGY; LIGAND BINDING;
D O I
10.1142/S0219633610005773
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
A series of norbornane-based HIV-1 protease (PR) inhibitors are designed theoretically to displace the tetrahedrally coordinated internal water molecule that bridges inhibitor to flaps via hydrogen bonds. These designed inhibitors use the norbornenone oxygen atom to mimic this structural water molecule and contain diols to interact with the carboxylate oxygens of catalytic aspartates. The binding free energies were estimated by modified linear interaction energy approach [Zoete H, Michielin O, Karplus M, J Comput Aided Mol Des 17: 861, 2003], in which the binding free energy is written as a linear combination of the electrostatic interaction energy between PR and the ligand, E-elec, the van der Waals interaction energy between PR and the ligand, E-vdW, and the difference of the solvation free energies of the complex, the receptor, and the isolated ligand, Delta G(solv). The equation obtained in previous work [Da W. Zhang, Philip Lin Huang, Sylvia Lee-Huang, John Z. H. Zhang, J Theor Comput Chem 7:485, 2008] is applied directly to calculate the binding free energy of designed norbornane-based HIV-1 PR inhibitors.
引用
收藏
页码:471 / 485
页数:15
相关论文
共 50 条
  • [31] Design strategies in the prodrugs of HIV-1 protease inhibitors to improve the pharmaceutical properties
    Subbaiah, Murugaiah A. M.
    Meanwell, Nicholas A.
    Kadow, John F.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 139 : 865 - 883
  • [32] Prenylisoflavonoids from Erythrina senegalensis as Novel HIV-1 Protease Inhibitors
    Lee, JiSuk
    Oh, Won Keun
    Ahn, Jong Seog
    Kim, Yong Hae
    Mbafor, J. Tanyi
    Wandji, Jean
    Fomum, Z. Tanee
    PLANTA MEDICA, 2009, 75 (03) : 268 - 270
  • [33] Comparative Molecular Field Analysis of a Series of Inhibitors of HIV-1 Protease
    Ferreira, Leonardo G.
    Leitao, Andrei
    Montanari, Carlos A.
    Andricopulo, Adriano D.
    MEDICINAL CHEMISTRY, 2011, 7 (02) : 71 - 79
  • [34] Biosensor analysis of the interaction of potential dimerization inhibitors with HIV-1 protease
    Ershov P.V.
    Gnedenko O.V.
    Molnar A.A.
    Lisitsa A.V.
    Ivanov A.S.
    Archakov A.I.
    Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2009, 3 (3) : 272 - 288
  • [35] Thermodynamic linkage between the binding of protons and inhibitors to HIV-1 protease
    Trylska, J
    Antosiewicz, J
    Geller, M
    Hodge, CN
    Klabe, RM
    Head, MS
    Gilson, MK
    PROTEIN SCIENCE, 1999, 8 (01) : 180 - 195
  • [36] Ionic derivatives of betulinic acid as novel HIV-1 protease inhibitors
    Zhao, Hua
    Holmes, Shaletha S.
    Baker, Gary A.
    Challa, Suresh
    Bose, Himangshu S.
    Song, Zhiyan
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2012, 27 (05) : 715 - 721
  • [37] Inhibitors of HIV-1 protease: 10 years after
    Mastrolorenzo, Antonio
    Rusconi, Stefano
    Scozzafava, Andrea
    Supuran, Claudiu T.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2006, 16 (08) : 1067 - 1091
  • [38] Effect of protease inhibitors on HIV-1 maturation and infectivity
    Jardine, DK
    Tyssen, DP
    Birch, CJ
    ANTIVIRAL RESEARCH, 2000, 45 (01) : 59 - 68
  • [39] A convergent synthesis of the spiroketal moiety of the HIV-1 protease inhibitors didemnaketals
    Yan, XJ
    Xin, L
    Bin, W
    Xue, ZZ
    Yong, QT
    TETRAHEDRON, 2002, 58 (09) : 1697 - 1708
  • [40] Genetic Variability of HIV-1 Protease from Nigeria and Correlation with Protease Inhibitors Drug Resistance
    Ana Carolina P. Vicente
    Simon M. Agwale
    Koko Otsuki
    O.M. Njouku
    D. Jelpe
    J.A. Idoko
    Elena Caride
    Rodrigo M. Brindeiro
    Amilcar Tanuri
    Virus Genes, 2001, 22 : 181 - 186